Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
July 9, 2008
Hepatocellular carcinoma developing years after extended field radiation for Hodgkin's lymphoma
Steven M Sorscher
Journal of Human Genetics
|
October 14, 2016
Estimating risk using multi-gene panel testing; do negative results change the risk?
Steven M Sorscher
Expert Opinion on Biological Therapy
|
March 22, 2007
Biological therapy update in colorectal cancer
Steven M Sorscher
The New England Journal of Medicine
|
September 17, 2004
EGFR mutations and sensitivity to gefitinib
Steven M Sorscher
Clinical Advances in Hematology & Oncology : H&O
|
September 16, 2005
Predicting recurrence risk for synchronous primary colon cancers
Steven M Sorscher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Discussing the Implications of Genetic Testing With Patients
Steven M Sorscher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2016
Next-Generation Sequencing of Tumors to Better Estimate the Clinical Significance of Non- BRCA Germline Deleterious Mutations
Steven M Sorscher
Journal of Neurosurgery
|
September 2, 2008
Metastasis in von hippel-lindau disease
Steven M Sorscher
Anti-Cancer Drugs
|
October 2, 2012
Explaining objective responses to zoledronic acid
Steven M Sorscher
Leukemia & Lymphoma
|
December 23, 2014
Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor
Armin Rashidi, Steven M Sorscher
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Acta Oncologica (Stockholm, Sweden)
|
July 9, 2008
Hepatocellular carcinoma developing years after extended field radiation for Hodgkin's lymphoma
Steven M Sorscher
Journal of Human Genetics
|
October 14, 2016
Estimating risk using multi-gene panel testing; do negative results change the risk?
Steven M Sorscher
Expert Opinion on Biological Therapy
|
March 22, 2007
Biological therapy update in colorectal cancer
Steven M Sorscher
The New England Journal of Medicine
|
September 17, 2004
EGFR mutations and sensitivity to gefitinib
Steven M Sorscher
Clinical Advances in Hematology & Oncology : H&O
|
September 16, 2005
Predicting recurrence risk for synchronous primary colon cancers
Steven M Sorscher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Discussing the Implications of Genetic Testing With Patients
Steven M Sorscher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2016
Next-Generation Sequencing of Tumors to Better Estimate the Clinical Significance of Non- BRCA Germline Deleterious Mutations
Steven M Sorscher
Journal of Neurosurgery
|
September 2, 2008
Metastasis in von hippel-lindau disease
Steven M Sorscher
Anti-Cancer Drugs
|
October 2, 2012
Explaining objective responses to zoledronic acid
Steven M Sorscher
Leukemia & Lymphoma
|
December 23, 2014
Temozolomide-associated myelodysplasia 6 years after treatment of a patient with pancreatic neuroendocrine tumor
Armin Rashidi, Steven M Sorscher
Page
of 3